VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q90094739  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241120235937.0
008     241120nneanz||abbn n and d
035 ‎‡a  (WKP)Q90094739‏
024 ‎‡a  0000-0002-8606-5889‏ ‎‡2  orcid‏
024 ‎‡a  56734026300‏ ‎‡2  scopus‏
035 ‎‡a  (OCoLC)Q90094739‏
043 ‎‡c  NZ‏
100 0 ‎‡a  Michael Sullivan‏ ‎‡c  paediatrician at the University of Otago‏ ‎‡9  en‏
375 ‎‡a  1‏ ‎‡2  iso5218‏
400 0 ‎‡a  Michael Sullivan‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
400 0 ‎‡a  মাইকেল সালিভান‏ ‎‡9  bn‏
670 ‎‡a  Author's A Clinical Decision Support System to Assist Pediatric Oncofertility: A Short Report‏
670 ‎‡a  Author's ANZCCSG BabyBrain99; intensified systemic chemotherapy, second look surgery and involved field radiation in young children with central nervous system malignancy.‏
670 ‎‡a  Author's Biallelic FANCD1/BRCA2 mutations predisposing to glioblastoma multiforme with multiple oncogenic amplifications‏
670 ‎‡a  Author's Carboplatin Hypersensitivity Reactions in Pediatric Low Grade Glioma Are Protocol Specific and Desensitization Shows Poor Efficacy.‏
670 ‎‡a  Author's Cystatin C Based Equation Accurately Estimates Glomerular Filtration Rate in Children With Solid and Central Nervous System Tumours: Enough Evidence to Change Practice?‏
670 ‎‡a  Author's Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation.‏
670 ‎‡a  Author's Early advice on managing children with cancer during the COVID-19 pandemic and a call for sharing experiences‏
670 ‎‡a  Author's Evidence of broad-based family support for the use of archival childhood tumour samples in future research‏
670 ‎‡a  Author's Fertility Preservation in Children and Adolescents With Cancer: Pilot of a Decision Aid for Parents of Children and Adolescents With Cancer‏
670 ‎‡a  Author's Germline-driven replication repair-deficient high-grade gliomas exhibit unique hypomethylation patterns‏
670 ‎‡a  Author's HG-53HYPERMUTATION AND NEOANTIGEN FORMATION PREDICT RESPONSE TO IMMUNE CHECKPOINT INHIBITION IN CHILDHOOD BIALLELIC MISMATCH REPAIR DEFICIENT GLIOBLASTOMA.‏
670 ‎‡a  Author's HGG-20. DNA METHYLATION ANALYSIS OF HIGH-GRADE GLIOMA IN PATIENTS WITH MISMATCH REPAIR DEFICIENCIES‏
670 ‎‡a  Author's Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.‏
670 ‎‡a  Author's LG-15RISK ASSESSMENT IN PAEDIATRIC GLIOMA - TIME TO MOVE ON FROM THE BINARY CLASSIFICATION.‏
670 ‎‡a  Author's LG-22METHYLATION PROFILING OF PAEDIATRIC PILOCYTIC ASTROCYTOMA REVEALS DIFFERENCES ASSOCIATED WITH TUMOUR LOCATION AND BEHAVIOUR.‏
670 ‎‡a  Author's LMI-01DEVELOPMENT OF CLINICAL GUIDELINES FOR THE TREATMENT OF LOW GRADE GLIOMAS IN LOWER AND LOWER MIDDLE INCOME COUNTRIES – A SIOP PODC INITIATIVE.‏
670 ‎‡a  Author's Long-term visual outcome after chemotherapy for optic pathway glioma in children: Site and age are strongly predictive‏
670 ‎‡a  Author's Low rates of recurrence and slow progression of pediatric pilocytic astrocytoma after gross-total resection: justification for reducing surveillance imaging.‏
670 ‎‡a  Author's Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group.‏
670 ‎‡a  Author's Methylation profiling of paediatric pilocytic astrocytoma reveals variants specifically associated with tumour location and predictive of recurrence.‏
670 ‎‡a  Author's Osteosarcoma in a Child Below 2 Years of Age: Case Report and Review of the Literature‏
670 ‎‡a  Author's Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)‏
670 ‎‡a  Author's Pediatric Pleomorphic Xanthoastrocytoma Treated With Surgical Resection Alone: Clinicopathologic Features‏
670 ‎‡a  Author's Pilocytic astrocytomas have telomere-associated promyelocytic leukemia bodies without alternatively lengthened telomeres‏
670 ‎‡a  Author's Reply to Comment on: Carboplatin Hypersensitivity Reactions in Pediatric Low Grade Glioma Are Protocol Specific and Desensitization Shows Poor Efficacy.‏
670 ‎‡a  Author's Report of a bi-allelic truncating germline mutation in TP53‏
670 ‎‡a  Author's Single agent carboplatin for pediatric low-grade glioma: A retrospective analysis shows equivalent efficacy to multiagent chemotherapy‏
670 ‎‡a  Author's SIOP PODC-adapted treatment guidelines for craniopharyngioma in low- and middle-income settings‏
670 ‎‡a  Author's SIOP PODC Adapted treatment guidelines for low grade gliomas in low and middle income settings‏
670 ‎‡a  Author's Sonic hedgehog, BMP4, and Hox genes in the development of anorectal malformations in Ethylenethiourea-exposed fetal rats‏
670 ‎‡a  Author's Sonic hedgehog expression in the development of hindgut in ETU-exposed fetal rats‏
670 ‎‡a  Author's The contribution of the sonic hedgehog cascade in the development of the enteric nervous system in fetal rats with anorectal malformations‏
670 ‎‡a  Author's The COVID-19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global‏
670 ‎‡a  Author's Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma‏
670 ‎‡a  Author's Wilms Tumor Associated With the 9q22.3 Microdeletion Syndrome: 2 New Case Reports and a Review of The Literature‏
909 ‎‡a  (scopus) 56734026300‏ ‎‡9  1‏
909 ‎‡a  (orcid) 0000000286065889‏ ‎‡9  1‏
919 ‎‡a  lg15riskassessmentinpaediatricgliomatimetomoveonfromthebinaryclassification‏ ‎‡A  LG-15RISK ASSESSMENT IN PAEDIATRIC GLIOMA - TIME TO MOVE ON FROM THE BINARY CLASSIFICATION.‏ ‎‡9  1‏
919 ‎‡a  pilocyticastrocytomashavetelomereassociatedpromyelocyticleukemiabodieswithoutalternativelylengthenedtelomeres‏ ‎‡A  Pilocytic astrocytomas have telomere-associated promyelocytic leukemia bodies without alternatively lengthened telomeres‏ ‎‡9  1‏
919 ‎‡a  hg53hypermutationandneoantigenformationpredictresponsetoimmunecheckpointinhibitioninchildhoodbiallelicmismatchrepairdeficientglioblastoma‏ ‎‡A  HG-53HYPERMUTATION AND NEOANTIGEN FORMATION PREDICT RESPONSE TO IMMUNE CHECKPOINT INHIBITION IN CHILDHOOD BIALLELIC MISMATCH REPAIR DEFICIENT GLIOBLASTOMA.‏ ‎‡9  1‏
919 ‎‡a  osteosarcomainachildbelow2yearsofagecasereportandreviewoftheliterature‏ ‎‡A  Osteosarcoma in a Child Below 2 Years of Age: Case Report and Review of the Literature‏ ‎‡9  1‏
919 ‎‡a  methylationprofilingofpaediatricpilocyticastrocytomarevealsvariantsspecificallyassociatedwithtumourlocationandpredictiveofrecurrence‏ ‎‡A  Methylation profiling of paediatric pilocytic astrocytoma reveals variants specifically associated with tumour location and predictive of recurrence.‏ ‎‡9  1‏
919 ‎‡a  medulloblastomadownunder2013areportfromthe3annualmeetingoftheinternationalmedulloblastomaworkinggroup‏ ‎‡A  Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group.‏ ‎‡9  1‏
919 ‎‡a  singleagentcarboplatinforpediatriclowgradegliomaaretrospectiveanalysisshowsequivalentefficacytomultiagentchemotherapy‏ ‎‡A  Single agent carboplatin for pediatric low-grade glioma: A retrospective analysis shows equivalent efficacy to multiagent chemotherapy‏ ‎‡9  1‏
919 ‎‡a  lowratesofrecurrenceandslowprogressionofpediatricpilocyticastrocytomaaftergrosstotalresectionjustificationforreducingsurveillanceimaging‏ ‎‡A  Low rates of recurrence and slow progression of pediatric pilocytic astrocytoma after gross-total resection: justification for reducing surveillance imaging.‏ ‎‡9  1‏
919 ‎‡a  disseminatedglioneuronaltumorsoccurringinchildhoodtreatmentoutcomesandbrafalterationsincludingv600emutation‏ ‎‡A  Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation.‏ ‎‡9  1‏
919 ‎‡a  longtermvisualoutcomeafterchemotherapyforopticpathwaygliomainchildrensiteandagearestronglypredictive‏ ‎‡A  Long-term visual outcome after chemotherapy for optic pathway glioma in children: Site and age are strongly predictive‏ ‎‡9  1‏
919 ‎‡a  lmi01developmentofclinicalguidelinesforthetreatmentoflowgradegliomasinlowerandlowermiddleincomecountriesasioppodcinitiative‏ ‎‡A  LMI-01DEVELOPMENT OF CLINICAL GUIDELINES FOR THE TREATMENT OF LOW GRADE GLIOMAS IN LOWER AND LOWER MIDDLE INCOME COUNTRIES – A SIOP PODC INITIATIVE.‏ ‎‡9  1‏
919 ‎‡a  earlyadviceonmanagingchildrenwithcancerduringthecovid19pandemicandacallforsharingexperiences‏ ‎‡A  Early advice on managing children with cancer during the COVID-19 pandemic and a call for sharing experiences‏ ‎‡9  1‏
919 ‎‡a  pediatricpleomorphicxanthoastrocytomatreatedwithsurgicalresectionaloneclinicopathologicfeatures‏ ‎‡A  Pediatric Pleomorphic Xanthoastrocytoma Treated With Surgical Resection Alone: Clinicopathologic Features‏ ‎‡9  1‏
919 ‎‡a  hgg20dnamethylationanalysisofhighgradegliomainpatientswithmismatchrepairdeficiencies‏ ‎‡A  HGG-20. DNA METHYLATION ANALYSIS OF HIGH-GRADE GLIOMA IN PATIENTS WITH MISMATCH REPAIR DEFICIENCIES‏ ‎‡9  1‏
919 ‎‡a  immunecheckpointinhibitionforhypermutantglioblastomamultiformeresultingfromgermlinebiallelicmismatchrepairdeficiency‏ ‎‡A  Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.‏ ‎‡9  1‏
919 ‎‡a  reportofabiallelictruncatinggermlinemutationintp53‏ ‎‡A  Report of a bi-allelic truncating germline mutation in TP53‏ ‎‡9  1‏
919 ‎‡a  replytocommentoncarboplatinhypersensitivityreactionsinpediatriclowgradegliomaareprotocolspecificanddesensitizationshowspoorefficacy‏ ‎‡A  Reply to Comment on: Carboplatin Hypersensitivity Reactions in Pediatric Low Grade Glioma Are Protocol Specific and Desensitization Shows Poor Efficacy.‏ ‎‡9  1‏
919 ‎‡a  lg22methylationprofilingofpaediatricpilocyticastrocytomarevealsdifferencesassociatedwithtumourlocationandbehaviour‏ ‎‡A  LG-22METHYLATION PROFILING OF PAEDIATRIC PILOCYTIC ASTROCYTOMA REVEALS DIFFERENCES ASSOCIATED WITH TUMOUR LOCATION AND BEHAVIOUR.‏ ‎‡9  1‏
919 ‎‡a  outcomesbyclinicalandmolecularfeaturesinchildrenwithmedulloblastomatreatedwithriskadaptedtherapyresultsofaninternationalphase3trialsjmb03‏ ‎‡A  Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)‏ ‎‡9  1‏
919 ‎‡a  wilmstumorassociatedwiththe9q223microdeletionsyndrome2newcasereportsandareviewoftheliterature‏ ‎‡A  Wilms Tumor Associated With the 9q22.3 Microdeletion Syndrome: 2 New Case Reports and a Review of The Literature‏ ‎‡9  1‏
919 ‎‡a  evidenceofbroadbasedfamilysupportfortheuseofarchivalchildhoodtumoursamplesinfutureresearch‏ ‎‡A  Evidence of broad-based family support for the use of archival childhood tumour samples in future research‏ ‎‡9  1‏
919 ‎‡a  useofbevacizumabasasingleagentorinadjunctwithtraditionalchemotherapyregimensinchildrenwithunresectableorprogressivelowgradeglioma‏ ‎‡A  Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma‏ ‎‡9  1‏
919 ‎‡a  covid19pandemicarapidglobalresponseforchildrenwithcancerfromsiopcogsiopesioppodcipsopros201andstjudeglobal‏ ‎‡A  The COVID-19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global‏ ‎‡9  1‏
919 ‎‡a  contributionofthesonichedgehogcascadeinthedevelopmentoftheentericnervoussysteminfetalratswithanorectalmalformations‏ ‎‡A  The contribution of the sonic hedgehog cascade in the development of the enteric nervous system in fetal rats with anorectal malformations‏ ‎‡9  1‏
919 ‎‡a  sonichedgehogexpressioninthedevelopmentofhindgutinetuexposedfetalrats‏ ‎‡A  Sonic hedgehog expression in the development of hindgut in ETU-exposed fetal rats‏ ‎‡9  1‏
919 ‎‡a  sonichedgehogbmp4andhoxgenesinthedevelopmentofanorectalmalformationsinethylenethioureaexposedfetalrats‏ ‎‡A  Sonic hedgehog, BMP4, and Hox genes in the development of anorectal malformations in Ethylenethiourea-exposed fetal rats‏ ‎‡9  1‏
919 ‎‡a  sioppodcadaptedtreatmentguidelinesforlowgradegliomasinlowandmiddleincomesettings‏ ‎‡A  SIOP PODC Adapted treatment guidelines for low grade gliomas in low and middle income settings‏ ‎‡9  1‏
919 ‎‡a  fertilitypreservationinchildrenandadolescentswithcancerpilotofadecisionaidforparentsofchildrenandadolescentswithcancer‏ ‎‡A  Fertility Preservation in Children and Adolescents With Cancer: Pilot of a Decision Aid for Parents of Children and Adolescents With Cancer‏ ‎‡9  1‏
919 ‎‡a  sioppodcadaptedtreatmentguidelinesforcraniopharyngiomainlowandmiddleincomesettings‏ ‎‡A  SIOP PODC-adapted treatment guidelines for craniopharyngioma in low- and middle-income settings‏ ‎‡9  1‏
919 ‎‡a  cystatin100basedequationaccuratelyestimatesglomerularfiltrationrateinchildrenwithsolidandcentralnervoussystemtumoursenoughevidencetochangepractice‏ ‎‡A  Cystatin C Based Equation Accurately Estimates Glomerular Filtration Rate in Children With Solid and Central Nervous System Tumours: Enough Evidence to Change Practice?‏ ‎‡9  1‏
919 ‎‡a  carboplatinhypersensitivityreactionsinpediatriclowgradegliomaareprotocolspecificanddesensitizationshowspoorefficacy‏ ‎‡A  Carboplatin Hypersensitivity Reactions in Pediatric Low Grade Glioma Are Protocol Specific and Desensitization Shows Poor Efficacy.‏ ‎‡9  1‏
919 ‎‡a  biallelicfancd1brca2mutationspredisposingtoglioblastomamultiformewithmultipleoncogenicamplifications‏ ‎‡A  Biallelic FANCD1/BRCA2 mutations predisposing to glioblastoma multiforme with multiple oncogenic amplifications‏ ‎‡9  1‏
919 ‎‡a  anzccsgbabybrain99intensifiedsystemicchemotherapy2looksurgeryandinvolvedfieldradiationinyoungchildrenwithcentralnervoussystemmalignancy‏ ‎‡A  ANZCCSG BabyBrain99; intensified systemic chemotherapy, second look surgery and involved field radiation in young children with central nervous system malignancy.‏ ‎‡9  1‏
919 ‎‡a  clinicaldecisionsupportsystemtoassistpediatriconcofertilityashortreport‏ ‎‡A  A Clinical Decision Support System to Assist Pediatric Oncofertility: A Short Report‏ ‎‡9  1‏
919 ‎‡a  germlinedrivenreplicationrepairdeficienthighgradegliomasexhibituniquehypomethylationpatterns‏ ‎‡A  Germline-driven replication repair-deficient high-grade gliomas exhibit unique hypomethylation patterns‏ ‎‡9  1‏
946 ‎‡a  b‏ ‎‡9  1‏
947 ‎‡a  NZ‏ ‎‡9  1‏
996 ‎‡2  RERO|A012678476‏
996 ‎‡2  NLA|000036002563‏
996 ‎‡2  ISNI|0000000109248596‏
996 ‎‡2  DNB|1022548603‏
996 ‎‡2  SUDOC|251301257‏
996 ‎‡2  J9U|987007429139805171‏
996 ‎‡2  NII|DA1329730X‏
996 ‎‡2  ISNI|0000000039426122‏
996 ‎‡2  ISNI|000000011469702X‏
996 ‎‡2  NUKAT|n 2007105662‏
996 ‎‡2  ISNI|0000000497044105‏
996 ‎‡2  ISNI|0000000109389380‏
996 ‎‡2  PLWABN|9810541398705606‏
996 ‎‡2  NSK|000468502‏
996 ‎‡2  BNF|16578696‏
996 ‎‡2  LC|no 97039956‏
996 ‎‡2  KRNLK|KAC200710041‏
996 ‎‡2  LC|nr2001036579‏
996 ‎‡2  LC|n 90716899‏
996 ‎‡2  CAOONL|ncf10726362‏
996 ‎‡2  NII|DA06223824‏
996 ‎‡2  BIBSYS|1560455408253‏
996 ‎‡2  NTA|09576691X‏
996 ‎‡2  LC|no2002111686‏
996 ‎‡2  DNB|1283205165‏
996 ‎‡2  BNF|15089812‏
996 ‎‡2  ISNI|0000000420260926‏
996 ‎‡2  NUKAT|n 2009113443‏
996 ‎‡2  LC|n 2004022454‏
996 ‎‡2  BIBSYS|9005586‏
996 ‎‡2  PLWABN|9814024546305606‏
996 ‎‡2  LC|n 88154183‏
996 ‎‡2  LC|n 79004494‏
996 ‎‡2  LC|no2019189277‏
996 ‎‡2  BLBNB|000990872‏
996 ‎‡2  NII|DA1603824X‏
996 ‎‡2  BNF|15644102‏
996 ‎‡2  CAOONL|ncf11445689‏
996 ‎‡2  NII|DA01004583‏
996 ‎‡2  ISNI|0000000108099269‏
996 ‎‡2  ISNI|0000000500872754‏
996 ‎‡2  CAOONL|ncf12139227‏
996 ‎‡2  LC|n 2009044710‏
996 ‎‡2  ISNI|0000000117165846‏
996 ‎‡2  BNF|14438441‏
996 ‎‡2  LC|no2017108190‏
996 ‎‡2  LIH|LNB:B_k__l_X;=CB‏
996 ‎‡2  NLR|RU NLR AUTH 770151124‏
996 ‎‡2  NLR|RU NLR AUTH 770151123‏
996 ‎‡2  DNB|1231368861‏
996 ‎‡2  DNB|1249240093‏
996 ‎‡2  NUKAT|n 2008056601‏
996 ‎‡2  BIBSYS|90558696‏
996 ‎‡2  LC|no2022116687‏
996 ‎‡2  LC|n 2003114737‏
996 ‎‡2  LC|no2002037350‏
996 ‎‡2  BIBSYS|90536101‏
996 ‎‡2  RERO|A023628471‏
996 ‎‡2  ISNI|0000000110224671‏
996 ‎‡2  DNB|1149703024‏
996 ‎‡2  ISNI|0000000055065347‏
996 ‎‡2  ISNI|0000000024429873‏
996 ‎‡2  DNB|1095673483‏
996 ‎‡2  ISNI|0000000084687268‏
996 ‎‡2  BNF|16071822‏
996 ‎‡2  ISNI|0000000066096771‏
996 ‎‡2  NTA|136560830‏
996 ‎‡2  LC|n 2013062992‏
996 ‎‡2  LC|no2018018098‏
996 ‎‡2  RERO|A016800031‏
996 ‎‡2  ISNI|0000000053961981‏
996 ‎‡2  NDL|001102722‏
996 ‎‡2  LC|no2024047800‏
996 ‎‡2  LC|no 96047485‏
996 ‎‡2  LC|n 2003013661‏
996 ‎‡2  KRNLK|KAC199626828‏
996 ‎‡2  BNF|17096070‏
996 ‎‡2  CAOONL|ncf11535086‏
996 ‎‡2  NTA|344097366‏
996 ‎‡2  ISNI|000000003302857X‏
996 ‎‡2  ISNI|0000000083243796‏
996 ‎‡2  BNF|12196354‏
996 ‎‡2  NUKAT|n 2009136028‏
996 ‎‡2  SUDOC|063465000‏
996 ‎‡2  PTBNP|157752‏
996 ‎‡2  BIBSYS|90053398‏
996 ‎‡2  ISNI|0000000072958745‏
996 ‎‡2  LC|nb 99056351‏
996 ‎‡2  BAV|495_274753‏
996 ‎‡2  RERO|A012345717‏
996 ‎‡2  SIMACOB|136540259‏
996 ‎‡2  BNF|13496772‏
996 ‎‡2  NKC|skuk0005466‏
996 ‎‡2  NII|DA17988255‏
996 ‎‡2  ISNI|0000000459819336‏
996 ‎‡2  B2Q|0000975822‏
996 ‎‡2  NII|DA02712068‏
996 ‎‡2  LC|n 97016299‏
996 ‎‡2  CAOONL|ncf11177763‏
996 ‎‡2  ISNI|0000000042413234‏
996 ‎‡2  CAOONL|ncf10149871‏
996 ‎‡2  DNB|133857034‏
996 ‎‡2  ISNI|0000000034766494‏
996 ‎‡2  NII|DA06214164‏
996 ‎‡2  NKC|xx0119200‏
996 ‎‡2  NDL|00458059‏
996 ‎‡2  LC|n 86800016‏
996 ‎‡2  ISNI|0000000038865641‏
996 ‎‡2  BLBNB|001040251‏
996 ‎‡2  BIBSYS|97011237‏
996 ‎‡2  LC|n 86056504‏
996 ‎‡2  NUKAT|n 2011074750‏
996 ‎‡2  J9U|987007324421105171‏
996 ‎‡2  DNB|1185545050‏
996 ‎‡2  CAOONL|ncf10160458‏
996 ‎‡2  BNF|10610135‏
996 ‎‡2  ISNI|0000000040597340‏
996 ‎‡2  RERO|A011720488‏
996 ‎‡2  RERO|A012349354‏
996 ‎‡2  SELIBR|280151‏
996 ‎‡2  ISNI|0000000037542613‏
996 ‎‡2  DNB|1045164518‏
996 ‎‡2  DNB|1304241149‏
996 ‎‡2  RERO|A012318577‏
996 ‎‡2  DNB|170501051‏
996 ‎‡2  ISNI|0000000114709510‏
996 ‎‡2  SUDOC|176157344‏
996 ‎‡2  BLBNB|001429830‏
996 ‎‡2  BNF|12059753‏
996 ‎‡2  ISNI|0000000078973671‏
996 ‎‡2  BIBSYS|4025454‏
996 ‎‡2  LC|n 88226224‏
996 ‎‡2  NLA|000035409938‏
996 ‎‡2  SUDOC|030575893‏
996 ‎‡2  SUDOC|15677125X‏
996 ‎‡2  RERO|A003875758‏
996 ‎‡2  LC|nb2022011980‏
996 ‎‡2  W2Z|1533887393165‏
996 ‎‡2  LC|no2013132431‏
996 ‎‡2  NKC|jx20091103009‏
996 ‎‡2  RERO|A012432813‏
996 ‎‡2  LC|n 98048613‏
996 ‎‡2  ISNI|0000000120335703‏
996 ‎‡2  LC|no2006030445‏
996 ‎‡2  LC|n 2014183825‏
996 ‎‡2  ISNI|000000041891357X‏
996 ‎‡2  DNB|174091869‏
996 ‎‡2  ERRR|12133127‏
996 ‎‡2  LC|n 2016041490‏
996 ‎‡2  NTA|326459324‏
996 ‎‡2  ISNI|0000000108974019‏
996 ‎‡2  CAOONL|ncf10053839‏
996 ‎‡2  CAOONL|ncf10938403‏
996 ‎‡2  CAOONL|ncf10938402‏
996 ‎‡2  NUKAT|n 97001352‏
996 ‎‡2  J9U|987007345845205171‏
996 ‎‡2  J9U|987007345157305171‏
996 ‎‡2  NLA|000036034004‏
996 ‎‡2  ISNI|0000000041799606‏
996 ‎‡2  ISNI|0000000077432486‏
996 ‎‡2  PLWABN|9810551073705606‏
996 ‎‡2  LC|n 2003033182‏
996 ‎‡2  RERO|A017417347‏
996 ‎‡2  SELIBR|280530‏
996 ‎‡2  LC|no2016125737‏
996 ‎‡2  BNF|16227295‏
996 ‎‡2  ISNI|0000000063129013‏
996 ‎‡2  RERO|A024599585‏
996 ‎‡2  BNF|16187069‏
996 ‎‡2  J9U|987007339471705171‏
996 ‎‡2  NTA|068593929‏
996 ‎‡2  LC|n 94036791‏
996 ‎‡2  LIH|LNB:SC_l_;=BY‏
996 ‎‡2  ISNI|000000007687395X‏
996 ‎‡2  SUDOC|256001898‏
996 ‎‡2  LC|no2009116865‏
996 ‎‡2  ISNI|0000000023607850‏
996 ‎‡2  PLWABN|9810641510705606‏
996 ‎‡2  LC|n 2019025667‏
996 ‎‡2  DNB|1248894162‏
996 ‎‡2  DNB|1216395268‏
996 ‎‡2  ISNI|0000000032216237‏
996 ‎‡2  LC|n 90620614‏
996 ‎‡2  LC|nb2019006616‏
996 ‎‡2  DNB|136308783‏
996 ‎‡2  LIH|LNB:DD6_t_;=BY‏
996 ‎‡2  LC|no2006108170‏
996 ‎‡2  LC|n 79142807‏
996 ‎‡2  LC|n 93015464‏
996 ‎‡2  CAOONL|ncf10170923‏
996 ‎‡2  NSK|000799377‏
996 ‎‡2  LC|n 2009020300‏
996 ‎‡2  ISNI|0000000046004702‏
996 ‎‡2  LNB|LNC10-000210358‏
996 ‎‡2  ISNI|0000000083661074‏
996 ‎‡2  DBC|87097969997864‏
996 ‎‡2  LC|no2016148449‏
996 ‎‡2  NII|DA01923942‏
996 ‎‡2  SUDOC|139526757‏
996 ‎‡2  PLWABN|9812614855005606‏
996 ‎‡2  BIBSYS|1533887393165‏
996 ‎‡2  NUKAT|n 2011214540‏
996 ‎‡2  PLWABN|9810546545805606‏
996 ‎‡2  LC|no2019178963‏
996 ‎‡2  LC|n 98012544‏
996 ‎‡2  SUDOC|279998872‏
996 ‎‡2  SUDOC|11044163X‏
996 ‎‡2  NUKAT|n 01023019‏
996 ‎‡2  J9U|987007386914505171‏
996 ‎‡2  LC|n 2019064870‏
996 ‎‡2  J9U|987007438079305171‏
996 ‎‡2  CAOONL|ncf11243424‏
996 ‎‡2  CAOONL|ncf12082995‏
996 ‎‡2  ERRR|12133115‏
996 ‎‡2  ISNI|0000000054452513‏
996 ‎‡2  LC|n 95053072‏
996 ‎‡2  NSK|000134684‏
996 ‎‡2  CAOONL|ncf11434147‏
996 ‎‡2  N6I|vtls000116760‏
996 ‎‡2  ISNI|0000000116980494‏
996 ‎‡2  SUDOC|196289793‏
996 ‎‡2  NKC|jo2014840830‏
996 ‎‡2  NUKAT|n 2017150280‏
996 ‎‡2  SUDOC|233228497‏
996 ‎‡2  LC|n 96027095‏
996 ‎‡2  NTA|32576980X‏
996 ‎‡2  NUKAT|n 2002040366‏
996 ‎‡2  ISNI|0000000081127740‏
996 ‎‡2  SELIBR|280148‏
996 ‎‡2  LC|nb2009002320‏
996 ‎‡2  ISNI|0000000041555564‏
996 ‎‡2  NII|DA04194725‏
996 ‎‡2  N6I|vtls001347394‏
996 ‎‡2  SUDOC|251408442‏
996 ‎‡2  NUKAT|n 01721557‏
996 ‎‡2  RERO|A003875760‏
996 ‎‡2  ISNI|0000000497795435‏
996 ‎‡2  ISNI|0000000083985976‏
996 ‎‡2  SUDOC|076980499‏
996 ‎‡2  LC|no2005056245‏
996 ‎‡2  J9U|987007437105605171‏
996 ‎‡2  DNB|1131078411‏
996 ‎‡2  LC|no2011166195‏
996 ‎‡2  ISNI|0000000072648843‏
996 ‎‡2  N6I|vtls000093169‏
996 ‎‡2  SUDOC|258129786‏
996 ‎‡2  DNB|1172213658‏
996 ‎‡2  ISNI|0000000357294399‏
996 ‎‡2  DNB|104850350X‏
996 ‎‡2  DNB|171507746‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏